Array Biopharma Inc (NASDAQ:ARRY)

15.75
Delayed Data
As of May 18
 0.00 / 0.00%
Today’s Change
7.15
Today|||52-Week Range
18.78
+23.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash68.6M55.7M56.6M125.9M
 
 
 
 
 
Short Term Investment Cash7.9M-12.9M907.0K69.3M
 
 
 
 
 
Cash & Short Term Investments111.0M178.3M109.9M234.3M
 
 
 
 
 
 
ReceivablesReceivables5.4M6.3M39.3M31.3M
 
 
 
 
 
 
InventoriesInventories----0.000.00--
 
Current AssetsOther Current Assets5.2M6.4M6.1M4.6M
 
 
 
 
 
Current Assets121.7M191.0M155.3M270.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross90.4M58.4M60.3M63.6M
 
 
 
 
 
Depreciation-82.3M-53.4M-53.6M-55.5M
 
 
 
 
 
Other Assets8.6M1.6M6.3M104.0K
 
 
 
 
 
Total Assets139.1M198.2M168.9M279.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable7.0M4.6M10.1M8.6M
 
 
 
 
 
Accrued Expenses11.5M20.1M20.2M33.0M
 
 
 
 
 
Other Current Liabilities37.6M30.3M33.7M50.7M
 
 
 
 
 
Other Liabilities52.7M42.4M52.4M69.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt104.0M107.3M113.7M133.9M
 
 
 
 
 
Other Liabilities640.0K496.0K4.8M6.6M
 
 
 
 
 
Total Liabilities164.8M155.6M206.8M267.4M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-25.7M42.7M-37.9M11.7M
 
 
 
 
 
Total Shareholder Equity-25.7M42.7M-37.9M11.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding131.8M142.1M143.7M171.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.